Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica

S.J. Hawthorne, M. Pagano, D.W. Halton, B. Walker

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A 30-kDa protease, purified previously from Fasciola hepatica, was sequenced and the first 15 N-terminal residues were found to be 100% homologous to a region in the protein Fcplc, which was cloned and expressed from F. hepatica. This terminal region was also 53 and 54% identical to two other cathepsin L-like proteases isolated from the same source. The 30-kDa protease demonstrated a specificity different from human cathepsin L when assayed with novel peptidyl enediones of the type Z-Phe-Ala-CH=CH2-CO2R (where R = Me/Et/Bu(t)). The ethyl ester peptide was a more efficient inhibitor of the protease than the corresponding methyl ester. This is in contrast to bovine cathepsin B and human cathepsin L where both are more readily inhibited by the methyl, rather than the ethyl ester peptide. These differences in the inhibition of the novel parasite protease may allow it to be exploited as a chemotherapeutic target.
LanguageEnglish
Pages79-82
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume277
Issue number1
DOIs
Publication statusPublished - 2000

Fingerprint

Cathepsin L
Fasciola hepatica
Peptide Hydrolases
Esters
Cathepsin B
Peptides
Protease Inhibitors
Parasites
Proteins

Cite this

@article{ecd7a0b192a14c648a13964ff37c5b73,
title = "Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica",
abstract = "A 30-kDa protease, purified previously from Fasciola hepatica, was sequenced and the first 15 N-terminal residues were found to be 100{\%} homologous to a region in the protein Fcplc, which was cloned and expressed from F. hepatica. This terminal region was also 53 and 54{\%} identical to two other cathepsin L-like proteases isolated from the same source. The 30-kDa protease demonstrated a specificity different from human cathepsin L when assayed with novel peptidyl enediones of the type Z-Phe-Ala-CH=CH2-CO2R (where R = Me/Et/Bu(t)). The ethyl ester peptide was a more efficient inhibitor of the protease than the corresponding methyl ester. This is in contrast to bovine cathepsin B and human cathepsin L where both are more readily inhibited by the methyl, rather than the ethyl ester peptide. These differences in the inhibition of the novel parasite protease may allow it to be exploited as a chemotherapeutic target.",
author = "S.J. Hawthorne and M. Pagano and D.W. Halton and B. Walker",
note = "cited By 5",
year = "2000",
doi = "10.1006/bbrc.2000.3633",
language = "English",
volume = "277",
pages = "79--82",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier",
number = "1",

}

Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica. / Hawthorne, S.J.; Pagano, M.; Halton, D.W.; Walker, B.

In: Biochemical and Biophysical Research Communications, Vol. 277, No. 1, 2000, p. 79-82.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Partial characterization of a novel cathepsin L-like protease from Fasciola hepatica

AU - Hawthorne, S.J.

AU - Pagano, M.

AU - Halton, D.W.

AU - Walker, B.

N1 - cited By 5

PY - 2000

Y1 - 2000

N2 - A 30-kDa protease, purified previously from Fasciola hepatica, was sequenced and the first 15 N-terminal residues were found to be 100% homologous to a region in the protein Fcplc, which was cloned and expressed from F. hepatica. This terminal region was also 53 and 54% identical to two other cathepsin L-like proteases isolated from the same source. The 30-kDa protease demonstrated a specificity different from human cathepsin L when assayed with novel peptidyl enediones of the type Z-Phe-Ala-CH=CH2-CO2R (where R = Me/Et/Bu(t)). The ethyl ester peptide was a more efficient inhibitor of the protease than the corresponding methyl ester. This is in contrast to bovine cathepsin B and human cathepsin L where both are more readily inhibited by the methyl, rather than the ethyl ester peptide. These differences in the inhibition of the novel parasite protease may allow it to be exploited as a chemotherapeutic target.

AB - A 30-kDa protease, purified previously from Fasciola hepatica, was sequenced and the first 15 N-terminal residues were found to be 100% homologous to a region in the protein Fcplc, which was cloned and expressed from F. hepatica. This terminal region was also 53 and 54% identical to two other cathepsin L-like proteases isolated from the same source. The 30-kDa protease demonstrated a specificity different from human cathepsin L when assayed with novel peptidyl enediones of the type Z-Phe-Ala-CH=CH2-CO2R (where R = Me/Et/Bu(t)). The ethyl ester peptide was a more efficient inhibitor of the protease than the corresponding methyl ester. This is in contrast to bovine cathepsin B and human cathepsin L where both are more readily inhibited by the methyl, rather than the ethyl ester peptide. These differences in the inhibition of the novel parasite protease may allow it to be exploited as a chemotherapeutic target.

U2 - 10.1006/bbrc.2000.3633

DO - 10.1006/bbrc.2000.3633

M3 - Article

VL - 277

SP - 79

EP - 82

JO - Biochemical and Biophysical Research Communications

T2 - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -